First vitiligo patient enrolled in afamelanotide monotherapy study 2022 Announcements . Clinical . Regulatory 20.10.2022
CLINUVEL PHARMACEUTICALS LTD Annual General Meeting – Notice of Meeting & Explanatory Memorandum 2022 2022 Announcements . Corporate . Regulatory 23.09.2022
CLINUVEL submits SCENESSE® label expansion for adolescent EPP patients 2022 Announcements . Clinical . Regulatory 05.09.2022
CLINUVEL Investor Webinar Financial Results Year Ended 30 June 2022 2022 Announcements . Financial . Regulatory 31.08.2022
Revenue Growth Drives CLINUVEL’s Sixth Consecutive Annual Profit 2022 Announcements . Financial . Regulatory 30.08.2022